TOTAL Talks Podcast

Welcome to the TOTAL Talks Podcast, where we dive into the latest trends, share inspiring stories, and offer expert insights into the evolving world of clinical trials. Each episode features conversations with industry leaders who are driving innovation and transforming the future of clinical research. Our goal is to highlight the importance of inclusivity and excellence at every stage of the process, ensuring that clinical trials are accessible and effective for all. Tune in to learn how TOTAL is shaping a more diverse and inclusive approach to clinical trials.

In Episode 3 of the podcast, host Sophie Tahiri speaks with Laquita Gilbert, Assistant Project Manager at TOTAL Diversity Clinical Trial Management. Laquita shares her personal story and expertise in developing FDA-compliant Diversity Action Plans, inspired by her family’s experience. The discussion covers Laquita’s journey in creating inclusive clinical trials, balancing FDA compliance, and overcoming challenges. She offers practical tips and key elements for successful Diversity Action Plans while emphasizing long-term commitment and measurable outcomes.

In Episode 2 of the podcast, host Sophie Tahiri speaks with Dr. Jerome Adams, former U.S. Surgeon General and TOTAL Diversity Chairman of the Board, about the FDA’s Diversity Action Plan and the Food and Drug Omnibus Reform Act (FDORA). They discuss the importance of these initiatives in promoting diversity and inclusion in clinical trials, particularly for underrepresented communities. Dr. Adams emphasizes the need for organizations to intentionally engage diverse populations, build trust, and address logistical barriers to participation. He envisions a future where diversity in clinical trials is standard, ultimately improving healthcare outcomes for all communities.

In this episode, Sophie Tahiri chats with Melynda Geurts, TOTAL’s Chief Commercial Officer, to explore how diversity is reshaping clinical trials. They discuss the innovative strategies TOTAL is using to drive change, improve inclusivity, and transform the landscape of clinical research. Whether you’re in the industry or simply interested in the future of healthcare, this episode offers valuable insights into the evolving world of clinical trials.